The captopril challenge test (CCT) is a non-invasive medical test that measures the change in reninplasma-levels in response to administration of captopril, an angiotensin converting enzyme inhibitor. It is used to assist in the diagnosis of renal artery stenosis. It is not generally considered a useful test for children,[1] and more suitable options are available for adult cases.
Procedure
Plasma concentration of renin is measured prior to and following the administration of captopril. The CCT is considered positive if the renin levels increase substantially or the baseline renin level is abnormally high.[2]
^Gauthier, B.; Trachtman, H.; Frank, R.; Pillari, G. (1991). "Inadequacy of captopril challenge test for diagnosing renovascular hypertension in children and adolescents". Pediatric Nephrology. 5 (1): 42–44. doi:10.1007/BF00852842. ISSN0931-041X. PMID2025535.
^Muller, F. B.; Sealey, J. E.; Case, D. B.; Atlas, S. A.; Pickering, T. G.; Pecker, M. S.; Preibisz, J. J.; Laragh, J. H. (1986). "The captopril test for identifying renovascular disease in hypertensive patients". The American Journal of Medicine. 80 (4): 633–644. doi:10.1016/0002-9343(86)90819-3. ISSN0002-9343. PMID3515933.
^Svetkey, L. P.; Himmelstein, S. I.; Dunnick, N. R.; Wilkinson, R. H.; Bollinger, R. R.; McCann, R. L.; Beytas, E. M.; Klotman, P. E. (1989). "Prospective analysis of strategies for diagnosing renovascular hypertension". Hypertension. 14 (3): 247–257. doi:10.1161/01.hyp.14.3.247. ISSN0194-911X. PMID2670763.